FLT3 and acute myeloid leukemia: Hence, our study is the first to evaluate the effects of genistein treatment on AML cells, using a two cell line model, with the cell line MV4-11 containing FLT3-ITD mutation and HL-60 with the wildtype FLT3 gene.